Skip to main content
Top

CNS Drugs

Issue 2/2014

Content (8 Articles)

Current Opinion

A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis

Ellen Lu, Bing Wei Wang, Sura Alwan, Anne Synnes, Leanne Dahlgren, A. Dessa Sadovnick, Helen Tremlett

Leading Article

Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders

Erin A. McClure, Cassandra D. Gipson, Robert J. Malcolm, Peter W. Kalivas, Kevin M. Gray

Review Article

Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs

Michael S. Abers, Wayne X. Shandera, Joseph S. Kass

Review Article

Clinical Relevance of Brain Volume Measures in Multiple Sclerosis

Nicola De Stefano, Laura Airas, Nikolaos Grigoriadis, Heinrich P. Mattle, Jonathan O’Riordan, Celia Oreja-Guevara, Finn Sellebjerg, Bruno Stankoff, Agata Walczak, Heinz Wiendl, Bernd C. Kieseier

Original Research Article

A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe

Virginie Gardette, Maryse Lapeyre-Mestre, Antoine Piau, Adeline Gallini, Christelle Cantet, Jean-Louis Montastruc, Bruno Vellas, Sandrine Andrieu